Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Overview
What you need to judge this in 30 seconds
미국 National Institutes of Health의 보조금/지원금 프로그램입니다. 지원 규모는 확인이 필요합니다. 접수 마감은 2027.12.23입니다. 현재 상태는 "모집중"입니다. 자부담과 지분 요구가 없습니다. The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic…
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in product development and entrepreneurship. This specific Catalyze Product Definition initiative will provide the early stage translational support needed for the activities required to develop and test device prototypes, identify diagnostic disease targets and develop associated assays, and develop research tools to treat HLBS diseases and disorders. This is a phased initiative for early stage projects. The R61 phase provides support to identify and test initial prototype designs, to identify a disease target and generate experimental design, and to identify, test and pilot research tools. The R33 phase provides support for continued prototype development and testing, in addition to modifying design features and user feedback, diagnostic product generation, exploration of assay components, and characterization of a load design, and research tool improvement, large trial testing and data integration. Following successful completion of the program, it is expected that the potential products will be poised to move forward for in vivo testing (optimization, safety, efficacy) with additional support from NIH and/or other federal and private programs. This initiative has a companion initiative that supports development of therapeutics and combination products and is also part of a suite of innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical Program.
- Category
- R&D
- Industry
- ICT & Software, Bio & Healthcare, Mobility
- Technology
- Medical Device, XR / Metaverse
- Target stage
- No limit
- Project duration
- Needs verification
- Estimated preparation
- 1–3 weeks
Funding
Award size and how it is paid
- Award range
- Needs verification
- Currency
- USD
- Total programme budget
- Needs verification
- Support type
- Cash
- Co-funding
- None (fully funded)
- Matching fund
- Needs verification
- Disbursement
- Reimbursement
- Note
- -
Eligibility
Can we actually apply?
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Company age
- No limit
- Employees
- No limit
- Revenue limits
- No limit
- Consortium
- Needs verification
Location Requirements
Geography and legal-entity conditions
- Primary country
- 🇺🇸 United States
- Also eligible
- None
- Foreign companies
- No
- Local entity
- Required
- Location condition
- 미국 연방 지원사업으로 미국 내 적격 신청주체가 필요합니다.
Required Documents
Required/optional · issuer · difficulty · validity · cautions
Document requirements were not captured (needs verification). Check the official announcement.
Application Process
How you apply
Application process not captured.
Evaluation
Review process and criteria
Evaluation process not captured.
Timeline
Announcement → intake → review → agreement → execution
Process steps were not captured.
Equity & Financial Terms
Equity, loans and contract conditions
- Equity required
- No
- Loan
- Non-dilutive grant
- Duplicate funding
- Needs verification
- IP ownership
- Retained by applicant
- Deliverable ownership
- Needs verification
- Exclusivity
- Needs verification
- Right of first refusal
- Needs verification
- Audit & settlement
- Standard
- Bayh-Dole 정부 실시권
미국 연방 R&D 자금 특성상 정부 실시권 조항이 적용될 수 있습니다.
근거: grants.gov 연방 지원사업 공통 조항 — 개별 공고 확인 필요
Risk Intelligence
Should we apply at all? — five dimensions plus an overall score (lower is safer)
Chance of failing eligibility, location or legal-entity rules
Co-funding, matching funds, reimbursement and loan exposure
Paperwork load, timeline pressure, reporting and audit duties
Exclusivity, right of first refusal, duplicate-funding limits
How much technical detail you must hand over, and who owns it
- 18현지 법인 필요
해당 국가에 법인이 없으면 지원할 수 없습니다.
- 18사후정산 방식
먼저 집행하고 이후 정산받으므로 현금흐름 부담이 큽니다.
- 16해외기업 지원 불가
자국 법인만 신청할 수 있습니다.
- 10제출서류 미확인· evidence needs verification
제출서류 목록이 확인되지 않았습니다.
- 7독점 조항 미확인· evidence needs verification
독점권 관련 조항을 확인해야 합니다.
- 6지원금액 미확인· evidence needs verification
지원 규모가 공고에서 확인되지 않았습니다.
- 6우선협상권 미확인· evidence needs verification
우선협상권 조항을 확인해야 합니다.
- 6중복수혜 규정 미확인· evidence needs verification
중복 수혜 가능 여부를 확인해야 합니다.
- · 제출서류 목록이 확인되지 않았습니다 — 기술자료 제출 범위를 공고문에서 직접 확인해야 합니다.
- · NDA 체결 가능 여부가 확인되지 않았습니다 (확인 필요).
- · 결과물 소유권 조항이 확인되지 않았습니다 (확인 필요).
- · 데이터 이용권 조항이 확인되지 않았습니다 (확인 필요).
- · 제출자료의 이용권 범위가 확인되지 않았습니다 (확인 필요).
- · 독점권 조항 유무가 확인되지 않았습니다 (확인 필요).
- · 우선협상권 조항 유무가 확인되지 않았습니다 (확인 필요).
- · Matching Fund 요건이 확인되지 않았습니다 (확인 필요).
- · 지원금액이 확인되지 않았습니다 (확인 필요).
- · 중복 수혜 제한 규정이 확인되지 않았습니다 (확인 필요).
Generated by local:rules-v1 · 56m ago
IP / Idea Protection
How much of your technology and idea you must disclose
제한적 공개를 권장합니다. 요구 자료 범위가 확인되지 않았습니다(노출 점수 45/100). 운영주체는 National Institutes of Health입니다. 미확인 항목 7건은 공고문·협약서에서 직접 확인이 필요합니다.
- NDA
- Needs verification
- IP ownership
- Retained by applicant
- Deliverable ownership
- Needs verification
- Data rights
- Needs verification
- Disclosure depth
- Needs verification
- File patent first?
- Not applicable
- Reuse of submissions
- Needs verification
- Publicity obligation
- Needs verification
- Exposure score
- 45 / 100
- · 제품/서비스가 해결하는 문제와 시장 정의
- · 고객 가치 제안(Value Proposition)과 정량적 성과 지표(개선율, 처리량 등)
- · 이미 공개된 특허 공보·논문·보도자료 내용
- · 팀 구성과 보유 역량, 수행 실적 요약
- · 아키텍처 레벨 다이어그램(모듈 단위, 내부 구현 제외)
- · 핵심 알고리즘의 수식·하이퍼파라미터·전처리 규칙
- · 학습 데이터 원본과 수집 파이프라인 상세
- · 소스코드 전체 및 빌드/배포 스크립트
- · 원가 구조와 단가 산출식
- · 고객사 실명·계약 조건·단가
- · 미출원 발명의 구체적 구현 방식
- MEDIUMNDA 체결 요청
상세 기술자료 제출 전 상호 비밀유지계약(NDA) 체결을 서면 요청하고, 불가하면 제출 자료를 요약 수준으로 제한하십시오.
5 evidence item(s) from the source
- UNKNOWN
제출서류 정보가 수집되지 않아 기술자료 노출 범위를 판정할 수 없습니다.
Source link - UNKNOWN
NDA 관련 조항을 확인할 수 없습니다.
Source link - HIGH
IP 귀속은 수행기업에 귀속됩니다.
Source link - UNKNOWN
결과물 소유권 조항을 확인할 수 없습니다.
Source link - HIGH
Bayh-Dole 정부 실시권: 미국 연방 R&D 자금 특성상 정부 실시권 조항이 적용될 수 있습니다.
Quote: “grants.gov 연방 지원사업 공통 조항 — 개별 공고 확인 필요”
Source link
- · 제출서류 목록이 확인되지 않았습니다 — 기술자료 제출 범위를 공고문에서 직접 확인해야 합니다.
- · NDA 체결 가능 여부가 확인되지 않았습니다 (확인 필요).
- · 결과물 소유권 조항이 확인되지 않았습니다 (확인 필요).
- · 데이터 이용권 조항이 확인되지 않았습니다 (확인 필요).
- · 제출자료의 이용권 범위가 확인되지 않았습니다 (확인 필요).
- · 독점권 조항 유무가 확인되지 않았습니다 (확인 필요).
- · 우선협상권 조항 유무가 확인되지 않았습니다 (확인 필요).
This assessment is derived from the stored announcement, document and contract fields. Anything the source does not state is marked "needs verification" — it never asserts that your idea will be taken. Generated by local:rules-v1 · 56m ago
AI Analysis
Pros · cons · difficulty · competition · attractiveness
From paperwork and review stages
Heuristic from award size and type
Amount, terms and IP combined
Weighted average of five dimensions
- + 지분 요구가 없어 희석 없이 자금을 확보할 수 있습니다.
- + 자부담 없이 전액 지원됩니다.
- + 개발 결과물의 IP가 수행기업에 귀속됩니다.
- − 사후정산 방식이므로 자금을 먼저 집행해야 합니다.
- − 현지 법인 설립이 필요합니다.
- − 해외 기업은 지원할 수 없습니다.
- ! 중복 수혜 제한 규정을 사전에 확인하십시오.
Similar Programs
Comparable by type, country and technology
- Postdoctoral Research Fellowships in Biology
🇺🇸 United States · Grant · U.S. National Science Foundation
$220K+D-49 - NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
🇺🇸 United States · Grant · National Institutes of Health
Needs verificationD-237 - NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
🇺🇸 United States · Grant · National Institutes of Health
Needs verificationD-968 - NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
🇺🇸 United States · Grant · National Institutes of Health
Needs verificationD-237 - Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
🇺🇸 United States · Grant · National Institutes of Health
Needs verificationRolling
Source & Provenance
Every value carries its source URL and fetch time
- Application URL
- https://www.grants.gov/search-results-detail/357339
- Last verified
- 2026.08.11
- First seen
- 2026.08.11
- Data status
- AI-parsed
- AI enrichment
- local:rules-v1 · 56m ago
- PRIMARYGrants.gov RFA-HL-26-019
Fetched 56m ago
- OFFICIAL_APIGrants.gov Search2 API
Fetched 56m ago
- · 56m ago — 변경 감지되어 갱신 (45fc3b74)
- · 1h ago — 변경 감지되어 갱신 (6ff63ac5)
- · 7h ago — 최초 수집 (162316df)